These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6040612)

  • 1. Identity and significance of some pink spots in schizophrenia and other conditions.
    Perry TL; Hansen S; MacDougall L
    Nature; 1967 Apr; 214(5087):484-5. PubMed ID: 6040612
    [No Abstract]   [Full Text] [Related]  

  • 2. Some observations concerning the "pink spot" reacting substances in urine.
    Watt JA; Ashcroft GW; Daly RJ; Smythies JR
    Acta Psychiatr Scand; 1970; 46(4):374-90. PubMed ID: 5502783
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the purification of a toxic factor in the urine of schizophrenic subjects].
    Fujita K
    Sapporo Igaku Zasshi; 1968; 33(1):12-21. PubMed ID: 5749368
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychotogenic N,N-Dimethylated indole amines and behavior in schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Recent Adv Biol Psychiatry; 1968; 10():6-15. PubMed ID: 4873523
    [No Abstract]   [Full Text] [Related]  

  • 7. Modifications of paper and thin layer chromatographic methods to increase sensitivity for detecting n-methylated indoleamines in urine.
    Tanimukai H
    J Chromatogr; 1967 Sep; 30(1):155-63. PubMed ID: 6057433
    [No Abstract]   [Full Text] [Related]  

  • 8. Amines and aphrodisiacs in chronic schizophrenia.
    Lovett Doust JW; Huszka L
    J Nerv Ment Dis; 1972 Oct; 155(4):261-4. PubMed ID: 5073357
    [No Abstract]   [Full Text] [Related]  

  • 9. A pink spot in thyrotoxicosis.
    Widelitz M; Feldman W
    Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913
    [No Abstract]   [Full Text] [Related]  

  • 10. Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease.
    Boulton AA; Pollitt RJ; Majer JR
    Nature; 1967 Jul; 215(5097):132-4. PubMed ID: 6049100
    [No Abstract]   [Full Text] [Related]  

  • 11. Urine volume and pink spots in schizophrenia and health.
    Watt JA; Ashcroft GW; Daly RJ; Smythies JR
    Nature; 1969 Mar; 221(5184):971-2. PubMed ID: 5765517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)].
    Stanciu E; Csiky K; Rácz E
    Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenelzine in anergic schizophrenia (clinical trials)].
    Di Genio R; Pellicanò C
    Osp Psichiatr; 1968; 36(3):457-64. PubMed ID: 5733535
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons of the "pink spot".
    Br Med J; 1967 Feb; 1(5537):382-3. PubMed ID: 6017504
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition and activation of caeruloplasmin by extracts from the urine of schizophrenic patients.
    Barrass BC; Coult DB; Drysdale AC; Marjot DH
    Biochem Pharmacol; 1970 May; 19(5):1675-9. PubMed ID: 5513947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 17. N-Monoacetylspermidine as a normal constituent of urine.
    Nakajima T; Zack JF; Wolfgram F
    Biochim Biophys Acta; 1969 Sep; 184(3):651-2. PubMed ID: 5822070
    [No Abstract]   [Full Text] [Related]  

  • 18. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.
    Barbeau A
    Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological determination of the toxicity of pathological body fluids. V. On the effect of amine fractions from urine extracts of mental and neurological patients].
    CHRIST H; RIEDER HP
    Confin Neurol; 1959; 19():319-28. PubMed ID: 13810061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.